Neuromodulation for Schizophrenia
RecruitingNCT05580211Phase: NAStarted 2023-10-03
Summary
Our proposed study employs a novel approach to determine the clinical and functional imaging effects of brainstem neuromodulation, with an investigational study device, on illness awareness in schizop
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Centre for Addiction and Mental HealthToronto, Ontario, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05580211